Literature DB >> 22343088

CT angiography of the aorta is superior to transesophageal echocardiography for determining stroke subtypes in patients with cryptogenic ischemic stroke.

A Chatzikonstantinou1, R Krissak, S Flüchter, D Artemis, A Schaefer, S O Schoenberg, M G Hennerici, C Fink.   

Abstract

BACKGROUND: The etiology of ischemic strokes remains cryptogenic in about one third of patients, even after extensive workup in specialized centers. Atherosclerotic plaques in the aorta can cause thromboembolic events but are often overlooked. They can elude standard identification by transesophageal echocardiography (TEE), which is invasive or at best uncomfortable for many patients. CT angiography (CTA) can be used as an alternative or in addition to TEE if this technique fails to visualize every part of the aorta and in particular the aortic arch.
METHODS: We prospectively studied 64 patients (47 men, age 60 ± 13 years) classified as having cryptogenic stroke after standard and full workup [including brain MRI and 24-hour electrocardiogram (ECG)] with ECG-triggered CTA of the aorta in search of plaques and compared the results with those of TEE. Investigators were blinded to the results of both techniques. Plaques were graded on CTA according to their presence (0 = not present; 1 = mild; 2 = severe) and degree of calcification (1a or 2a = noncalcified; 1b or 2b = calcified). Associations with risk factors and infarct localization were also assessed.
RESULTS: Only 21 of 64 patients (32.8%) had aortic plaques identified by TEE, compared to 43 of 64 (67.2%) with CTA (p < 0.05). The plaque localization was as follows (TEE vs. CTA): ascending aorta, 10 vs. 20 (p < 0.05); aortic arch, 10 vs. 40 (p < 0.05), and descending aorta, 20 vs. 34 (p < 0.05). Grade 1 plaques were most commonly found in the aortic arch (25; 39%), while grade 2 plaques were most often detected in the aortic arch (15; 23.4%) and the descending aorta (14; 21.9%). There was no significant correlation between plaque location, infarct territory or vascular risk profile, except for hypertension (p = 0.003), which was significantly associated with the presence of plaques.
CONCLUSIONS: CTA identifies more plaques throughout the aortic arch and around the origins of the major cerebral arteries in particular compared to TEE. These may represent potential embolic sources of acute ischemic stroke. Better plaque detection may have an impact on the best available secondary prevention regimen in individual patients if proximal embolic sources are suspected.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22343088     DOI: 10.1159/000335828

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  9 in total

1.  Aortic arch and common carotid artery plaques with soft components pose a substantial risk of cerebral embolization during carotid stenting.

Authors:  Péter Szikra; Krisztina Boda; Ferenc Rarosi; Attila Thury; Pál Barzó; Tamás Németh; Erika Vörös
Journal:  Interv Neuroradiol       Date:  2016-02-25       Impact factor: 1.610

2.  Non-invasive volumetric assessment of aortic atheroma: a core laboratory validation using computed tomography angiography.

Authors:  Muhammad Hammadah; Mohammed Qintar; Steven E Nissen; Julie St John; Saqer Alkharabsheh; Motunrayo Mobolaji-Lawal; Femi Philip; Kiyoko Uno; Yu Kataoka; Brett Babb; Roman Poliszczuk; Samir R Kapadia; E Murat Tuzcu; Paul Schoenhagen; Stephen J Nicholls; Rishi Puri
Journal:  Int J Cardiovasc Imaging       Date:  2015-05-12       Impact factor: 2.357

3.  Aortic arch calcification, procedural times, and outcomes of endovascular treatment in patients with acute ischemic stroke.

Authors:  Adnan I Qureshi; Haseeb A Rahman; Malik M Adil; Ameer E Hassan; Jefferson T Miley
Journal:  J Vasc Interv Neurol       Date:  2014-06

4.  Increasing severity of aortic atherosclerosis in coronary artery bypass grafting patients evaluated by transesophageal echocardiography.

Authors:  John T Denny; Enrique Pantin; Antonio Chiricolo; James Tse; Julia E Denny; Sagar S Mungekar; Darrick Chyu; Alann Solina
Journal:  J Clin Med Res       Date:  2014-10-16

5.  Semiautomatic Volumetry of Low Attenuation of Thoracic Aortic Plaques on Curved Planar Reformations Using MDCT Angiographic Data with 0.5 mm Collimation.

Authors:  Kenji Mizutani; Izumi Torimoto; Zenjiro Sekikawa; Toshiaki Nishii; Takashi Kawasaki; Keiichiro Kasama; Takahisa Goto; Shigeo Takebayashi
Journal:  Biomed Res Int       Date:  2018-05-22       Impact factor: 3.411

6.  Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke.

Authors:  Georgios Tsivgoulis; Apostolos Safouris; Dong-Eog Kim; Andrei V Alexandrov
Journal:  J Stroke       Date:  2018-05-31       Impact factor: 6.967

Review 7.  Expert opinion paper on cardiac imaging after ischemic stroke.

Authors:  Renate B Schnabel; Stephan Camen; Fabian Knebel; Andreas Hagendorff; Udo Bavendiek; Michael Böhm; Wolfram Doehner; Matthias Endres; Klaus Gröschel; Andreas Goette; Hagen B Huttner; Christoph Jensen; Paulus Kirchhof; Grigorios Korosoglou; Ulrich Laufs; Jan Liman; Caroline Morbach; Darius Günther Nabavi; Tobias Neumann-Haefelin; Waltraud Pfeilschifter; Sven Poli; Timolaos Rizos; Andreas Rolf; Joachim Röther; Wolf Rüdiger Schäbitz; Thorsten Steiner; Götz Thomalla; Rolf Wachter; Karl Georg Haeusler
Journal:  Clin Res Cardiol       Date:  2021-06-18       Impact factor: 5.460

8.  Aortic Complex Plaque Predicts the Risk of Cryptogenic Ischemic Cerebrovascular Disease Recurrence.

Authors:  Jing Dong; Xin Ma; Jingyuan Qie; Xunming Ji
Journal:  Aging Dis       Date:  2016-03-15       Impact factor: 6.745

9.  Coronary artery bypass grafting and perioperative stroke: imaging of atherosclerotic plaques in the ascending aorta with ungated high-pitch CT-angiography.

Authors:  Ulrika Asenbaum; Richard Nolz; Stefan B Puchner; Tobias Schoster; Lukas Baumann; Julia Furtner; Daniel Zimpfer; Guenther Laufer; Christian Loewe; Sigrid E Sandner
Journal:  Sci Rep       Date:  2020-08-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.